Telomerase and breast cancer
Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in n...
שמור ב:
| הוצא לאור ב: | Breast Cancer Res |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2001
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11305948/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr288 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|